ESTRO Multidisciplinary Management of Breast Cancer 2017

Can systemic endocrine therapy remove the need for clear margins?

• Houssami meta-analysis showed +ve margin had significant negative effect even when adjusted for anti-oestrogen use and ER status.

• The NSABP B14 Trial of Tamoxifen versus placebo demonstrated a 14 versus 4% LRR